China's drug regulator approved mazdutide as a Category 1 innovative drug in June for long-term weight management in adults with obesity and related metabolic conditions. According to Innovent, it is ...

The imminent Indian patent expiry of Novo Nordisk’s global blockbuster anti-diabetic and weight loss treatment drug – the GLP ...

As Indian drug giants rush to export weight-loss drug semaglutide in countries that don’t have patent exclusivity, they face ...

Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of ...

The arrival of GLP-1 medications like Ozempic® and Wegovy® has been nothing short of revolutionary for weight loss and diabetes management. These drugs, which include active ingredients like ...

Thousands of Australians would get access to a popular weight-loss jab on the PBS to treat obesity, under a proposal green lit by an independent government committee.

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

A long-awaited decision published on Friday lays the groundwork for weight-loss drugs to be subsidised for more patients with ...

Good news for people on GLP-1 therapy who hate needles: Trial data out this week shows that an experimental pill developed by ...

Thousands of Australians would get access to a popular weight-loss jab on the PBS to treat obesity, under a proposal green ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Clinic Secret is a telehealth platform providing licensed access to GLP-1 weight loss treatments like Ozempic, semaglutide ...